For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the introduction of this treatment and Attruby represents a significant change. These innovative therapies stabilize the transthyretin protein, preventing its destructive build-up and alleviating the burden of the disease . Individuals are now seein